​

Funding Round

Series A - Ten63 Therapeutics

Series A - Ten63 Therapeutics

Investment Firm

Overview

Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the world’s most lethal diseases.

Announced Date

May 02, 2023

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Hatteras Venture Partners

Hatteras Venture Partners

Hatteras Venture Partners is a convertible_note and early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

6

Investor Name
Participant InvestorAlexandria Venture Investments
Participant InvestorMorpheus Ventures
Participant InvestorHatteras Venture Partners
Participant InvestorSOSV
Participant InvestorDraper Associates

Round Details and Background

Ten63 Therapeutics raised $15900000 on 2023-05-02 in Series A

Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the world’s most lethal diseases.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 27, 2019
Seed Round - Ten63 Therapeutics
2-undefined
Jan 07, 2021
Seed Round - Ten63 Therapeutics
2-undefined
May 02, 2023
Series A - Ten63 Therapeutics
6-15.9M

Recent Activity

There is no recent news or activity for this profile.